Ketamine is challenging to dose—specially in powder form—and when people overdose, they may practical experience possibly deadly side effects, such as central nervous system inhibition that can result in cardiac arrest. In March of 2019, the S(+) stereoisomer of ketamine known as esketamine was authorized through the FDA as a https://australianl877iwm4.bloggazzo.com/profile